Literature DB >> 13842983

Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.

O H WARWICK, J M DARTE, T C BROWN, C T BEER, J H CUTTS, R L NOBLE.   

Abstract

Entities:  

Keywords:  ALKALOIDS/therapy; ANTINEOPLASTIC AGENTS/therapy

Mesh:

Substances:

Year:  1960        PMID: 13842983

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

1.  THE CHEMOTHERAPY OF MALIGNANT DISEASE--PRACTICAL AND EXPERIMENTAL CONSIDERATIONS.

Authors:  J MATTHIAS
Journal:  Postgrad Med J       Date:  1965-05       Impact factor: 2.401

2.  Clinical experience with vinblastine sulfate.

Authors:  O H WARWICK; R E ALISON; J M DARTE
Journal:  Can Med Assoc J       Date:  1961-09-02       Impact factor: 8.262

3.  Immunotherapy of a patient with choriocarcinoma.

Authors:  B CINADER; M A HAYLEY; W D RIDER; O H WARWICK
Journal:  Can Med Assoc J       Date:  1961-02-11       Impact factor: 8.262

4.  The Positive Signs of Neurosis.

Authors:  D B Guest
Journal:  Can Med Assoc J       Date:  1961-09-02       Impact factor: 8.262

5.  Electron microscopy on the effect of vinblastine on the telencephalic wall of the rat fetus.

Authors:  I K Takeuchi; Y K Takeuchi; U Murakami
Journal:  Br J Exp Pathol       Date:  1977-10

6.  [Long term treatment of advanced lymphogranulomatosis with vinblastine sulfate].

Authors:  E Schulz; W Jüngling; K Hausmann
Journal:  Klin Wochenschr       Date:  1969-02-15

7.  Change in taste preference related to aging of taste cells in rat.

Authors:  K Sugimoto; T Sato
Journal:  Experientia       Date:  1978-05-15

8.  O. Harold Warwick: Canada's first medical oncologist.

Authors:  D H Cowan
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

9.  Hodgkin's disease and some solid tumours.

Authors:  A M Jelliffe
Journal:  Proc R Soc Med       Date:  1966-12

10.  Clinical experience with vincaleukoblastine sulfate in the treatment of 11 patients with Hodgkin's disease.

Authors:  K R Butler
Journal:  Can Med Assoc J       Date:  1965-10-02       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.